Guidelines for the Management of Multidrug-Resistant and Other Epidemiologically Important Organisms along the Health Care Continuum
The Delaware Division of Public Health (DPH) receives many inquiries from non-acute, residential care facilities along the health care continuum, including but not limited to nursing homes, rehabilitation centers, psychiatric and assisted living facilities, regarding the appropriateness of placement and care of persons with multidrug-resistant organisms (MDRO). The most common questions concern persons who are colonized or infected with methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant enterococcus (VRE), and increasingly those with highly resistant Gram-negative bacilli (GNB), such as carbapenem-resistant Enterobacteriaceae (CRE), Pseudomonas, and Acinetobacter species.
This guideline is intended to address all of the above “epidemiologically important” organisms, which for the purposes of this document will be collectively referred to using the general term MDRO. Guidance that is pertinent only to specific organisms will be designated as such. Read the guidelines.
Delaware Health Equity Guide: Changing How We Think About Good Health
Good health is more than simply a visit to the doctor. Only about 10 percent of a person’s health status is impacted by traditional medical care. Health is also directly impacted by where people live, work, play, and pray. To empower communities to address these larger environmental issues, the Division of Public Health (DPH) and members of the University of Delaware’s School of Public Policy & Administration released today the Health Equity Guide for Public Health Practitioners and Partners.
Poverty, homelessness, crime, hunger, discrimination, unintended pregnancy, and education attainment can be linked to a risk of elevated rates of disease, disability, injury, and premature death. Since such factors extend far beyond traditional public health efforts, DPH hopes the Health Equity Guide will catalyze strong partnerships between public health, health care, businesses, schools, religious organizations, and lawmakers. The document shares evidence-based and promising strategies, and provides numerous references and web links for additional information. Read the Health Equity Guide.
For further information, call 302-744-4879.
Delaware Primary Care Health Needs Assessment 2015
Assessing populations and areas with unmet health care needs, disparities, and access barriers to support designations of health professional shortage areas and the recruitment and retention of primary care providers. Read the Assessment.
The Burden of Asthma in Delaware (Update)
The Division of Public Health (DPH), working with the Delaware Asthma Consortium and the Department of Natural Resources and Environmental Control (DNREC), published the first report on The Burden of Asthma in Delaware
in 2005. These parties met again 2015 to update the report. Read the report.
DEA Intelligence Report: The Drug Situation in Delaware
In April 2016, the Drug Enforcement Administration’s (DEA) Philadelphia Field Division (PFD) Intelligence Program conducted an analysis of drug availability and abuse for the State of Delaware. Delaware is home to 935,000 people in three counties: New Castle (including the city of Wilmington), Kent, and Sussex. The primary drug threats to Delaware are heroin and diverted prescription opioids, as measured through information regarding drug availability, seizures, treatment admissions, and drug-related overdose deaths. In 2014, Wilmington ranked third on the Federal Bureau of Investigation’s annual list of the most violent cities of comparable size, and it ranked fifth in violent crime when compared to all cities with populations greater than 50,000. As a result, Wilmington was included in the Department of Justice’s Violence Reduction Network in 2014. In 2015, the Office of National Drug Control Policy designated New Castle County as part of the Philadelphia/Camden High Intensity Drug Trafficking Area (HIDTA). Read the full report.
Delaware HIV Surveillance Report 2016
The Delaware Division of Public Health (DPH) initiated AIDS surveillance and reporting in 1981. In 2001, surveillance was expanded to include data on Delawareans infected with HIV. The surveillance relies on data compiled from healthcare professionals and laboratories throughout the state. Read the full report.